The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug containing the stable isotope — deuterium — in place of a hydrogen atom) to be approved by ...
Proton transfer is central to numerous important systems, from biology to energy storage. Probing the details of proton ...
The global deuterated drugs market, valued at US$ 334.0 million in 2023, presents a robust growth pattern. With a projected valuation of US$ 871.8 million by 2032 at a CAGR of 11.25%, the market is ...
Discover Sun Pharmaceutical's new patent for synthesizing D-serine-2-d, detailing innovative methods and versatile compounds for advanced pharmaceutical applications.
"We are making rapid advancements in our two lead clinical programs – CYB003, our proprietary deuterated psilocin program in development for the adjunctive treatment of Major Depressive Disorder ...
We have two assets in the clinic at the moment. Our CYB003 program, which is a deuterated psilocin, has completed Phase 2. We have some really spectacular Phase 2 results that I'd be happy to ...
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...
These novel forms of DMT (deuterated DMT) have longer durations than DMT when delivered intravenously and may even make oral delivery possible. “We developed a library of deuterated forms and ...
Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Processa Pharmaceuticals (PCSA – Research Report), retaining the ...
Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed ...
除了2-壬醛这种物质会让老人身上有味道外,还有一些来自饮食、生活习惯、疾病的原因,也会让他们的体味更明显。 尤其是一些年纪越大越容易患慢性疾病。 [1]Haze, S., et al., 2-Nonenal Newly Found in Human ...
Kulkarni’s optimism is fueled by the upcoming Phase 2 data for CYB003, a deuterated psilocybin analog for major depressive disorder (MDD), expected in early C4Q24. The initiation of Phase 3 ...